NKNisha Hemandhar Kumar

Nisha Hemandhar Kumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nisha Hemandhar Kumar has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteo-transcriptomic reprogramming and resource reallocation define the aging mammalian brain

    by Nisha Hemandhar-Kumar, Verena Kluever, Svenja V. Kaufmann, Cornelius Bergmann, Kanaan Mousaei, Miguel Tomas, Miguel Correa Marrero, Avika Chopra, Misa Hirose, Mercè Pallas, et al.

    Brain aging is a major risk for neurodegeneration, yet the underlying molecular mechanisms remain poorly understood. Here we performed an integrative proteo-transcriptomic analysis of the aging mouse brain, uncovering molecular signatures of aging through the assessment of protein aggregation, mRNA relocalization, and comparative proteomics across eight models of premature aging and neurodegeneration. We identified dynamic changes in physiological aging highlighting differences in synaptic maintenance and energy-allocation. These were linked to changes associated with fundamental protein biochemical properties such as size and net charge. Network analysis highlighted a decrease in mitochondrial complex I proteins not compensated at the mRNA level. Aggregation of 60S ribosome subunits indicated deteriorating translation efficiency and was accompanied by mitochondrial and proteasomal imbalance. The analysis of the nine models revealed key similarities and differences between physiological aging and pathology. Overall, our study provides an extensive resource on molecular aging, and offers insights into mechanisms predisposing to neurodegeneration, easily accessible at our Brain Aging and Molecular Atlas Project (BrainAging-MAP) website.

  • Open Access

    Site-specific metabolic labeling reveals proteome-wide phospho-dynamics

    by Mihai Alevra, Miguel Correa Marrero, Verena Kluever, Sunit Mandad, Nisha Hemandhar-Kumar, Kuan-Ting Pan, Julian van Gerwen, Selda Kabatas Glowacki, Hanna Wildhagen, Till Ischebeck, et al.

    Protein phosphorylation is a critical post-translational modification that orchestrates cellular signaling. Here, we introduce PulsPhos, a method combining metabolic labeling with phosphoproteomics, spectral analysis and modeling, to quantify site-specific phosphorylation lifetimes in living cells. Phosphosite lifetimes vary over multiple orders of magnitude and are influenced by factors such as amino acid composition and subcellular localization. PulsPhos was readily applied to pharmacological perturbations revealing fundamental mechanisms governing protein phosphorylation dynamics.

  • Open Access

    Comprehensive transcriptome analysis reveals altered mRNA splicing and post-transcriptional changes in the aged mouse brain

    by Nisha Hemandhar Kumar, Verena Kluever, Emanuel Barth, Sebastian Krautwurst, Mattia Furlan, Mattia Pelizzola, Manja Marz, Eugenio F Fornasiero

    A comprehensive understanding of molecular changes during brain aging is essential to mitigate cognitive decline and delay neurodegenerative diseases. The interpretation of mRNA alterations during brain aging is influenced by the health and age of the animal cohorts studied. Here, we carefully consider these factors and provide an in-depth investigation of mRNA splicing and dynamics in the aging mouse brain, combining short- and long-read sequencing technologies with extensive bioinformatic analyses. Our findings encompass a spectrum of age-related changes, including differences in isoform usage, decreased mRNA dynamics and a module showing increased expression of neuronal genes. Notably, our results indicate a reduced abundance of mRNA isoforms leading to nonsense-mediated RNA decay and suggest a regulatory role for RNA-binding proteins, indicating that their regulation may be altered leading to the reshaping of the aged brain transcriptome. Collectively, our study highlights the importance of studying mRNA splicing events during brain aging.


  • Open Access

    Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration

    by Verena Kluever, Belisa Russo, Sunit Mandad, Nisha Hemandhar Kumar, Mihai Alevra, Alessandro Ori, Silvio O. Rizzoli, Henning Urlaub, Anja Schneider, Eugenio F. Fornasiero

    Aging is a prominent risk factor for neurodegenerative disorders (NDDs); however, the molecular mechanisms rendering the aged brain particularly susceptible to neurodegeneration remain unclear. Here, we aim to determine the link between physiological aging and NDDs by exploring protein turnover using metabolic labeling and quantitative pulse-SILAC proteomics. By comparing protein lifetimes between physiologically aged and young adult mice, we found that in aged brains protein lifetimes are increased by ~20% and that aging affects distinct pathways linked to NDDs. Specifically, a set of neuroprotective proteins are longer-lived in aged brains, while some mitochondrial proteins linked to neurodegeneration are shorter-lived. Strikingly, we observed a previously unknown alteration in proteostasis that correlates to parsimonious turnover of proteins with high biosynthetic costs, revealing an overall metabolic adaptation that preludes neurodegeneration. Our findings suggest that future therapeutic paradigms, aimed at addressing these metabolic adaptations, might be able to delay NDD onset.


  • Computational analysis to identify the drug targets and their lead molecules in pancreatic cancer

    by H. Nisha, Balasankar Karavadi, Aswathy

    Pancreatic cancer is the leading cause of cancer related deaths. Metastasis and drug resistance are the major causes of mortality in patients with pancreatic cancer. There are several genes which are responsible for causing pancreatic cancer; they have the ability to enhance the tumor growth. The 96 protein coding genes which are targets for cancer-causing mutations in pancreatic cancers are considered. Some of the effective proteins were identified and the structures are determined using homology modeling. In this study we performed the homology modeling studies of the Activin receptor type 1 B(ACVR1B) and Transmembrane protease serine 4(TMPRSS4) proteins which are protein coding genes and validated the nature of the receptor as a future drug target for pancreatic cancer treatment and diagnosis. We have also identified specific ligands for the above mentioned protein by using the effective structure based ligand screening approach. Protein ligand complexes have been analyzed by docking studies using Autodock vina and interactions have also been visualized. Finally, the best drugs i.e. the ligands or small molecules are validated for ADMET and Physiochemical properties.